Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors
Hutchmed
Hutchmed
Federation Francophone de Cancerologie Digestive
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Boston Scientific Corporation
Amgen
Eli Lilly and Company
Eli Lilly and Company
H. Lee Moffitt Cancer Center and Research Institute
Yale University
Yale University
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute